Notice for Orelabrutinib (Innocare Pharma Australia Pty Ltd)
Active ingredients
Orelabrutinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
tablet
Indication
Treatment of Mantle cell lymphoma (MCL)
Therapeutic area
Haematology